| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/02/2002 | EP1165513A1 Indolinone compounds as kinase inhibitors |
| 01/02/2002 | EP1165510A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
| 01/02/2002 | EP1165197A1 Crystallization process for producing fine crystal products |
| 01/02/2002 | EP1165068A1 C10 heterosubstituted acetate taxanes as antitumor agents |
| 01/02/2002 | EP0912553B1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/02/2002 | EP0835256B1 Microbicidal benzotriazoles |
| 01/02/2002 | EP0764157B1 Benzopyrans and their use as therapeutic agents |
| 01/02/2002 | EP0731091B1 2-oxoindoline derivatives as cholecystokinin receptor antagonists |
| 01/02/2002 | CN1329609A Tetrahydrobenza epine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
| 01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
| 01/02/2002 | CN1329597A Pyridinium derivatives for treatment of diabetic and aging-related vascular complications |
| 01/02/2002 | CN1077106C 吡唑衍生物 Pyrazole derivative |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335452 1-substituted 2,5-dithienyl pyrrole derivatives and film-forming materials |
| 01/01/2002 | US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 01/01/2002 | US6335362 Antitumor and anticarcinogenic agents for leukemia |
| 01/01/2002 | US6335357 1-aryl-3-cyano-5-(het)arylalkylaminopyrazole derivatives; insecticides for agriculture and horticulture |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335329 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/01/2002 | US6335327 1-benzazepine derivatives; agonists or antagonists of vasopressin and/or oxytocin |
| 01/01/2002 | CA2056799C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/01/2002 | CA2029105C Halogenated sulphonylaminocarbonyltriazolinones |
| 12/27/2001 | WO2001098310A1 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001098290A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | WO2001098289A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | WO2001098286A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | WO2001098272A1 Novel compounds |
| 12/27/2001 | WO2001032646A3 Sulfonamide derivatives |
| 12/27/2001 | WO2000064864A9 N-protected amines and their use as prodrugs |
| 12/27/2001 | US20010056184 Pipecolinic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | US20010056105 Useful as cosmetic for hair and body hygiene, and for treatment of dermatological complaints, with an inflammatory and/or immunoallergic component of rheumatic or respiratory type, cardivascular and opthalmogical disorders |
| 12/27/2001 | US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 12/27/2001 | US20010056096 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
| 12/27/2001 | CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | CA2411963A1 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same |
| 12/27/2001 | CA2411585A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | CA2411255A1 Novel compounds |
| 12/27/2001 | CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/26/2001 | CN1328552A Pyrimidone derivatives |
| 12/26/2001 | CN1328549A Substituted benzo [de] isoquinoline-1,3-diones |
| 12/26/2001 | CN1328546A Pyrrolidines as inhibitors of neuraminidases |
| 12/26/2001 | CN1328455A Use of N-substituted azabicycloalkane derivatives for treating diseases of central nervous system |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333346 Aminofuranoneureas or thioureas 4-amino-2(5h)-thiophenones as antitumor agents |
| 12/25/2001 | US6333344 Prolines as antimicrobial agents |
| 12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
| 12/25/2001 | US6333338 Anticoagulants, cardiovascular disorders |
| 12/25/2001 | US6333324 For therapy and prophylaxis of matrix metalloproteinases (mmp) or tumor necrosis factor .alpha. (tnf.alpha.), mediated diseases |
| 12/25/2001 | CA2052424C 2-(4-piperidinyl)-1h-pyrido¬4,3-b|indol-1-ones and related compounds, intermediates and a process for their preparation |
| 12/20/2001 | WO2001096331A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | WO2001096330A2 Thrombin receptor antagonists |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096314A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 12/20/2001 | WO2001096313A1 Distamycin a analogs |
| 12/20/2001 | WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 12/20/2001 | WO2001096303A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
| 12/20/2001 | WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 12/20/2001 | WO2001096295A2 2-cyanopyrrolidine derivatives and their use as medicaments |
| 12/20/2001 | WO2001095911A1 Protease inhibitors |
| 12/20/2001 | WO2001095858A2 Piperazinedione compounds |
| 12/20/2001 | WO2001040223A3 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 12/20/2001 | WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 12/20/2001 | WO1999019304A3 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
| 12/20/2001 | US20010053788 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity |
| 12/20/2001 | CA2719176A1 2-cyanopyrrolidine derivatives and their use as medicaments |
| 12/20/2001 | CA2412353A1 Protease inhibitors |
| 12/20/2001 | CA2412216A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | CA2412010A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 12/20/2001 | CA2411805A1 Serine protease inhibitors |
| 12/20/2001 | CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors |
| 12/19/2001 | EP1164134A1 Benzimidazole compounds and their use as modulators of the GABA A receptor complex |
| 12/19/2001 | EP1163238A1 Chemokine recpetor binding heterocyclic compounds |
| 12/19/2001 | EP1163237A1 Amide derivatives |
| 12/19/2001 | EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents |
| 12/19/2001 | EP1163229A1 2,4-diamino-1,3,5-triazines, method for producing them and their use as herbicides and plant growth regulators |
| 12/19/2001 | EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists |
| 12/19/2001 | EP0785794B1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 12/19/2001 | EP0639080B1 Non-azo naphthalimide dyes and use as alkylating agents |
| 12/19/2001 | CN1327443A Substituted anilides |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331639 By reacting a 3-((alkyl, alkoxy, phenyl or heteroaryl)carbonylamino)thiophene with a ketone in the presence of an acid and reducing the reaction mixture; agricultural fungicides |
| 12/18/2001 | US6331637 N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/18/2001 | US6331634 Process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
| 12/18/2001 | US6331554 Antipicornaviral compounds, compositions containing them, and methods for their use |
| 12/18/2001 | US6331545 Heterocycyclic piperidines as modulators of chemokine receptor activity |
| 12/18/2001 | US6331544 Treating positive and negative symptoms of schizophrenia and other psychoses |
| 12/18/2001 | US6331537 Treating neurological disorders in animals |
| 12/18/2001 | US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 12/18/2001 | CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process |
| 12/13/2001 | WO2001094339A1 Substituted pyridine herbicides |
| 12/13/2001 | WO2001094317A2 Method for synthesis of substituted azole libraries |
| 12/13/2001 | WO2001093841A2 Barbituric acid analogs as therapeutic agents |
| 12/13/2001 | WO2001093682A1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives |
| 12/13/2001 | WO2001068140A3 Opioid formulations |
| 12/13/2001 | WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters |